Management Team

Riikka Havunen

PhD, VP of Operations

VP of Operations, Riikka Havunen, has over a decade’s experience on oncolytic viruses and cancer immunotherapy. Riikka had a key role in development of TILT-123, which was the focus of her PhD. Riikka heads TILT’s Quality Affairs and is responsible for maintaining and developing the company’s Quality Management System, which she built on the basis of ISO9001. Riikka is a multitalented expert in CMC and participates also in preclinical strategy planning and other business operations.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Aino Kalervo

MSc, MS, Chief Operating Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Prof, Chief Regulatory Officer, Chair of the Board of Directors

Juha Pihlman

BSc, CFO consultant

Suvi Sorsa

PhD, VP of Clinical Affairs

Víctor Cervera-Carrascón

PhD, VP of Business Development

Hanna Kirk

MSc, VP of Product Development

John Goldfinch

MBA, CRM, US Clinical Lead

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

João Manuel Santos

PhD, Head of Translational Medicine

Henrik Roosvall

BSc, Business Operations Manager

James Clubb

MSc, Project Manager

Dafne Quixabeira

PhD, Project Manager

Katja Saarikko

Operations Coordinator

Sini Raatikainen

MSc, Lab Manager

Sanae Zahraoui

Supply Chain Manager

Lyna Haybout

MD, Medical Monitor

Minna Oksanen

MSc, Office Manager

Remi Gloeckler

PhD, CMC Advisor